Paper279296
Mechanisms of reduction of antitumor drug toxicity by liposome encapsulation.
Rahman YE and 4 others. Ann N Y Acad Sci, 1978. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms of reduction of antitumor drug toxicity by liposome encapsulation. Papers, record 279296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/279296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dactinomycin | Major topic |
| Liposomes | Major topic |
| Animals | |
| Antibody Formation | |
| Bone Marrow | |
| Intestinal Mucosa | |
| Mice | |
| Spleen |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39861690 | Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39861690 | PubMed |
| 23620664 | Clinical significance of metallothioneins in cell therapy and nanomedicine. | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/23620664 | PubMed |
| 22866157 | Synergistic antitumor effects of liposomal honokiol combined with cisplatin in colon cancer models. | Oncol Lett | 2011 | https://conductscience.org/library/papers/22866157 | PubMed |
| 18350317 | Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer. | J Cancer Res Clin Oncol | 2008 | https://conductscience.org/library/papers/18350317 | PubMed |
| 7860226 | Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome). | Invest New Drugs | 1994 | https://conductscience.org/library/papers/7860226 | PubMed |
| 7506649 | Liposomes as carriers of cancer chemotherapy. Current status and future prospects. | Drugs | 1993 | https://conductscience.org/library/papers/7506649 | PubMed |
| 7218338 | Thermodynamics of partitioning and efflux of phenothiazines from liposomes. | J Membr Biol | 1981 | https://conductscience.org/library/papers/7218338 | PubMed |
| 7073945 | Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7073945 | PubMed |
| 6940195 | Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6940195 | PubMed |
| 389479 | Potential of liposomes as drug-carriers in cancer chemotherapy: a review. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/389479 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/279296
GET https://conductscience.org/api/papers/v1/279296/authors